iomeprol has been researched along with Cardiomyopathy, Dilated in 1 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
Cardiomyopathy, Dilated: A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreini, D | 1 |
| Pontone, G | 1 |
| Pepi, M | 1 |
| Ballerini, G | 1 |
| Bartorelli, AL | 1 |
| Magini, A | 1 |
| Quaglia, C | 1 |
| Nobili, E | 1 |
| Agostoni, P | 1 |
1 trial available for iomeprol and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Diagnostic accuracy of multidetector computed tomography coronary angiography in patients with dilated cardiomyopathy.
Topics: Artifacts; Cardiomyopathy, Dilated; Contrast Media; Coronary Angiography; Coronary Artery Disease; C | 2007 |